Analysis of immune responses to attenuated alcelaphine herpesvirus 1 formulated with and without adjuvant. (2021)

First Author: Russell GC
Attributed to:  Development of a vaccination strategy for the control of malignant catarrhal fever funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jvacx.2021.100090

PubMed Identifier: 33912826

Publication URI: http://europepmc.org/abstract/MED/33912826

Type: Journal Article/Review

Volume: 8

Parent Publication: Vaccine: X

ISSN: 2590-1362